# Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients

> **NCT01395901** · PHASE3 · COMPLETED · sponsor: **Helsinn Healthcare SA** · enrollment: 670 (actual)

## Conditions studied

- Postoperative Nausea and Vomiting

## Interventions

- **DRUG:** Palonosetron
- **DRUG:** Ondansetron
- **DRUG:** Placebo to Ondansetron
- **DRUG:** Placebo to Palonosetron

## Key facts

- **NCT ID:** NCT01395901
- **Lead sponsor:** Helsinn Healthcare SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2012-03
- **Final completion:** 2012-04
- **Target enrollment:** 670 (ACTUAL)
- **Last updated:** 2014-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01395901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01395901, "Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01395901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*